Tremors, Volume 163 in the International Review in Neurobiology serial highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
1. Introduction - p. 1 2. Chapter One: Is essential tremor a family of diseases or a syndrome? A family of diseases - p. 7 3. Chapter Two: Is essential tremor a family of diseases or a syndrome? A syndrome - p. 36 4. Section II - p. 59 5. Section II: Essential tremor: Is this an electrical or a degenerative disorder? Or is it both? - p. 59 6. Introduction - p. 61 7. Chapter Three: Is essential tremor a degenerative disorder or an electric disorder? Degenerative disorder - p. 73 8. Chapter Four: Is essential tremor a degenerative or an electrical disorder? Electrical disorder - p. 103 9. Section III - p. 128 10. Section III: How important is the inferior olive in essential tremor? An evolving story - p. 128 11. Introduction - p. 129 12. Chapter Five: Is the inferior olive central to essential tremor? Yes - p. 133 13. Chapter Six: Is inferior olive central to the pathophysiology of essential tremor? No - p. 167 14. Section IV - p. 187 15. Section IV: Essential tremor as a harbinger: What is the cognitive fallout of having essential tremor? - p. 187 16. Introduction - p. 189 17. Chapter Seven: Does essential tremor increase risk of cognitive impairment and dementia? Yes - p. 195 18. Chapter Eight: Does essential tremor increase the risk of dementia? No - p. 233 19. Section V - p. 253 20. Section V: Is essential tremor a disorder primarily due to GABA dysfunction? - p. 253 21. Introduction - p. 255 22. Chapter Nine: Is essential tremor a disorder of primary GABA dysfunction? Yes - p. 259 23. Chapter Ten: Is essential tremor a disorder of GABA dysfunction? No - p. 285 24. Section VI - p. 310 25. Section VI: The future of pharmacotherapies for essential tremor: Enhancing GABA neurotransmission or reducing neuronal hyperexcitability? - p. 310 26. Introduction - p. 311 27. Chapter Eleven: Enhancing GABA inhibition is the next generation of medications for essential tremor - p. 317 28. Chapter Twelve: Reduction of neuronal hyperexcitability with modulation of T-type calcium channel or SK channel in essential tremor - p. 335
Tremors, Volume 163 in the International Review in Neurobiology serial highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
1. Introduction - p. 1 2. Chapter One: Is essential tremor a family of diseases or a syndrome? A family of diseases - p. 7 3. Chapter Two: Is essential tremor a family of diseases or a syndrome? A syndrome - p. 36 4. Section II - p. 59 5. Section II: Essential tremor: Is this an electrical or a degenerative disorder? Or is it both? - p. 59 6. Introduction - p. 61 7. Chapter Three: Is essential tremor a degenerative disorder or an electric disorder? Degenerative disorder - p. 73 8. Chapter Four: Is essential tremor a degenerative or an electrical disorder? Electrical disorder - p. 103 9. Section III - p. 128 10. Section III: How important is the inferior olive in essential tremor? An evolving story - p. 128 11. Introduction - p. 129 12. Chapter Five: Is the inferior olive central to essential tremor? Yes - p. 133 13. Chapter Six: Is inferior olive central to the pathophysiology of essential tremor? No - p. 167 14. Section IV - p. 187 15. Section IV: Essential tremor as a harbinger: What is the cognitive fallout of having essential tremor? - p. 187 16. Introduction - p. 189 17. Chapter Seven: Does essential tremor increase risk of cognitive impairment and dementia? Yes - p. 195 18. Chapter Eight: Does essential tremor increase the risk of dementia? No - p. 233 19. Section V - p. 253 20. Section V: Is essential tremor a disorder primarily due to GABA dysfunction? - p. 253 21. Introduction - p. 255 22. Chapter Nine: Is essential tremor a disorder of primary GABA dysfunction? Yes - p. 259 23. Chapter Ten: Is essential tremor a disorder of GABA dysfunction? No - p. 285 24. Section VI - p. 310 25. Section VI: The future of pharmacotherapies for essential tremor: Enhancing GABA neurotransmission or reducing neuronal hyperexcitability? - p. 310 26. Introduction - p. 311 27. Chapter Eleven: Enhancing GABA inhibition is the next generation of medications for essential tremor - p. 317 28. Chapter Twelve: Reduction of neuronal hyperexcitability with modulation of T-type calcium channel or SK channel in essential tremor - p. 335
